Kevin D. Stewart

AstraZeneca (United States)

Papers

1

Total Citations

13

H-Index

1

About

Kevin D. Stewart is a leading researcher in bioprocess engineering, with a focused expertise in virus filtration and high-throughput process development for biopharmaceutical manufacturing. His work addresses critical challenges in the purification of mammalian cell culture-derived therapeutics, where ensuring viral safety is paramount. Stewart’s major contribution lies in pioneering a novel high-throughput screening tool for virus filtration, detailed in his most-cited 2020 paper (13 citations). This innovation overcomes the limitations of traditional bench-scale models that demand large filter load volumes and costly virus clearance studies, enabling faster, more efficient process optimization. By reducing material and resource requirements, his approach accelerates the development of safer, more robust manufacturing workflows for biologics. Stewart’s research is highly impactful within the bioprocessing community, offering practical solutions to industry bottlenecks. His work not only advances fundamental understanding of filtration dynamics but also provides tangible tools for process development scientists, bridging the gap between laboratory research and commercial-scale production.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
A novel high-throughput process development screening tool for virus filtration
13 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: AstraZeneca (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago